Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11951100 Formulations of RBP4 inhibitors and methods of use

Patent 11951100 was granted and assigned to Belite Bio on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Cheng-Chi Irene Wang0

Yu-Hsin Tom Lin0

Date of Patent

April 9, 2024

0

Patent Application Number

184600800

Date Filed

September 1, 2023

0

Patent Citations

US Patent 9434727 Substituted 4-phenylpiperidines, their preparation and use

0

US Patent 9487509 Heterocyclic compound

0

US Patent 9637450 Octahydrocyclopentapyrroles, their preparation and use

0

US Patent 9777010 Substituted 4-phenylpiperidines, their preparation and use

0

US Patent 9926271 Octahydrocyclopentapyrroles, their preparation and use

0

US Patent 9938291 N-alkyl-2-phenoxyethanamines, their preparation and use

0

US Patent 9944644 Octahydropyrrolopyrroles their preparation and use

0

US Patent 10245259 Methods of treating RBP4 related diseases with triazolopyridines

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as macular degeneration and the like.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11951100 Formulations of RBP4 inhibitors and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool